ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tadalafil Oral Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-21L10464
Home | Market Reports | Health| Reproductive Health
Global and United States Tadalafil Oral Market Report Forecast 2022 2028
BUY CHAPTERS

Global Tadalafil Oral Market Research Report 2025

Code: QYRE-Auto-21L10464
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
TEVA
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan NV
Cipla Ltd
Ajanta Pharma Ltd.
Dr Reddys Laboratories
Qilu Pharmaceutical

Tadalafil Oral Market Size

The global market for Tadalafil Oral was valued at US$ 135 million in the year 2024 and is projected to reach a revised size of US$ 173 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Tadalafil Oral Market

Tadalafil Oral Market

Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent market research reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tadalafil Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tadalafil Oral.
The Tadalafil Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tadalafil Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tadalafil Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tadalafil Oral Market Report

Report Metric Details
Report Name Tadalafil Oral Market
Accounted market size in year US$ 135 million
Forecasted market size in 2031 US$ 173 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 2.5 mg tablets
  • 5 mg tablets
  • 10mg tablets
  • 20 mg tablets
Segment by Application
  • Hospital
  • Drug store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Teva, Aurobindo, Sun Pharma, Alembic Pharmaceuticals, Mylan, Cipla, Ajanta Pharma Ltd., Dr. Reddys Laboratories, Qilu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tadalafil Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tadalafil Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tadalafil Oral Market growing?

Ans: The Tadalafil Oral Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Tadalafil Oral Market size in 2031?

Ans: The Tadalafil Oral Market size in 2031 will be US$ 173 million.

Who are the main players in the Tadalafil Oral Market report?

Ans: The main players in the Tadalafil Oral Market are Eli Lilly, Teva, Aurobindo, Sun Pharma, Alembic Pharmaceuticals, Mylan, Cipla, Ajanta Pharma Ltd., Dr. Reddys Laboratories, Qilu Pharmaceutical

What are the Application segmentation covered in the Tadalafil Oral Market report?

Ans: The Applications covered in the Tadalafil Oral Market report are Hospital, Drug store

What are the Type segmentation covered in the Tadalafil Oral Market report?

Ans: The Types covered in the Tadalafil Oral Market report are 2.5 mg tablets, 5 mg tablets, 10mg tablets, 20 mg tablets

Recommended Reports

Sexual Dysfunction Drugs

Urology Equipment

Oral Pharmaceutical APIs

1 Tadalafil Oral Market Overview
1.1 Product Definition
1.2 Tadalafil Oral by Type
1.2.1 Global Tadalafil Oral Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5 mg tablets
1.2.3 5 mg tablets
1.2.4 10mg tablets
1.2.5 20 mg tablets
1.3 Tadalafil Oral by Application
1.3.1 Global Tadalafil Oral Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Tadalafil Oral Market Size Estimates and Forecasts
1.4.1 Global Tadalafil Oral Revenue 2020-2031
1.4.2 Global Tadalafil Oral Sales 2020-2031
1.4.3 Global Tadalafil Oral Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tadalafil Oral Market Competition by Manufacturers
2.1 Global Tadalafil Oral Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tadalafil Oral Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tadalafil Oral Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tadalafil Oral, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tadalafil Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tadalafil Oral, Product Type & Application
2.7 Global Key Manufacturers of Tadalafil Oral, Date of Enter into This Industry
2.8 Global Tadalafil Oral Market Competitive Situation and Trends
2.8.1 Global Tadalafil Oral Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tadalafil Oral Players Market Share by Revenue
2.8.3 Global Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tadalafil Oral Market Scenario by Region
3.1 Global Tadalafil Oral Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tadalafil Oral Sales by Region: 2020-2031
3.2.1 Global Tadalafil Oral Sales by Region: 2020-2025
3.2.2 Global Tadalafil Oral Sales by Region: 2026-2031
3.3 Global Tadalafil Oral Revenue by Region: 2020-2031
3.3.1 Global Tadalafil Oral Revenue by Region: 2020-2025
3.3.2 Global Tadalafil Oral Revenue by Region: 2026-2031
3.4 North America Tadalafil Oral Market Facts & Figures by Country
3.4.1 North America Tadalafil Oral Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tadalafil Oral Sales by Country (2020-2031)
3.4.3 North America Tadalafil Oral Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tadalafil Oral Market Facts & Figures by Country
3.5.1 Europe Tadalafil Oral Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tadalafil Oral Sales by Country (2020-2031)
3.5.3 Europe Tadalafil Oral Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tadalafil Oral Market Facts & Figures by Region
3.6.1 Asia Pacific Tadalafil Oral Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tadalafil Oral Sales by Region (2020-2031)
3.6.3 Asia Pacific Tadalafil Oral Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tadalafil Oral Market Facts & Figures by Country
3.7.1 Latin America Tadalafil Oral Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tadalafil Oral Sales by Country (2020-2031)
3.7.3 Latin America Tadalafil Oral Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tadalafil Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Tadalafil Oral Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tadalafil Oral Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tadalafil Oral Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tadalafil Oral Sales by Type (2020-2031)
4.1.1 Global Tadalafil Oral Sales by Type (2020-2025)
4.1.2 Global Tadalafil Oral Sales by Type (2026-2031)
4.1.3 Global Tadalafil Oral Sales Market Share by Type (2020-2031)
4.2 Global Tadalafil Oral Revenue by Type (2020-2031)
4.2.1 Global Tadalafil Oral Revenue by Type (2020-2025)
4.2.2 Global Tadalafil Oral Revenue by Type (2026-2031)
4.2.3 Global Tadalafil Oral Revenue Market Share by Type (2020-2031)
4.3 Global Tadalafil Oral Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tadalafil Oral Sales by Application (2020-2031)
5.1.1 Global Tadalafil Oral Sales by Application (2020-2025)
5.1.2 Global Tadalafil Oral Sales by Application (2026-2031)
5.1.3 Global Tadalafil Oral Sales Market Share by Application (2020-2031)
5.2 Global Tadalafil Oral Revenue by Application (2020-2031)
5.2.1 Global Tadalafil Oral Revenue by Application (2020-2025)
5.2.2 Global Tadalafil Oral Revenue by Application (2026-2031)
5.2.3 Global Tadalafil Oral Revenue Market Share by Application (2020-2031)
5.3 Global Tadalafil Oral Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Tadalafil Oral Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Tadalafil Oral Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Aurobindo
6.3.1 Aurobindo Company Information
6.3.2 Aurobindo Description and Business Overview
6.3.3 Aurobindo Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Tadalafil Oral Product Portfolio
6.3.5 Aurobindo Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Company Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharma Tadalafil Oral Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Company Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alembic Pharmaceuticals Tadalafil Oral Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Tadalafil Oral Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Tadalafil Oral Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Ajanta Pharma Ltd.
6.8.1 Ajanta Pharma Ltd. Company Information
6.8.2 Ajanta Pharma Ltd. Description and Business Overview
6.8.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ajanta Pharma Ltd. Tadalafil Oral Product Portfolio
6.8.5 Ajanta Pharma Ltd. Recent Developments/Updates
6.9 Dr. Reddys Laboratories
6.9.1 Dr. Reddys Laboratories Company Information
6.9.2 Dr. Reddys Laboratories Description and Business Overview
6.9.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dr. Reddys Laboratories Tadalafil Oral Product Portfolio
6.9.5 Dr. Reddys Laboratories Recent Developments/Updates
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Company Information
6.10.2 Qilu Pharmaceutical Description and Business Overview
6.10.3 Qilu Pharmaceutical Tadalafil Oral Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Qilu Pharmaceutical Tadalafil Oral Product Portfolio
6.10.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tadalafil Oral Industry Chain Analysis
7.2 Tadalafil Oral Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tadalafil Oral Production Mode & Process Analysis
7.4 Tadalafil Oral Sales and Marketing
7.4.1 Tadalafil Oral Sales Channels
7.4.2 Tadalafil Oral Distributors
7.5 Tadalafil Oral Customer Analysis
8 Tadalafil Oral Market Dynamics
8.1 Tadalafil Oral Industry Trends
8.2 Tadalafil Oral Market Drivers
8.3 Tadalafil Oral Market Challenges
8.4 Tadalafil Oral Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly
TEVA
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan NV
Cipla Ltd
Ajanta Pharma Ltd.
Dr Reddys Laboratories
Qilu Pharmaceutical
List of Tables
 Table 1. Global Tadalafil Oral Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tadalafil Oral Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tadalafil Oral Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tadalafil Oral Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tadalafil Oral Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tadalafil Oral Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tadalafil Oral Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tadalafil Oral Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tadalafil Oral, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tadalafil Oral, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tadalafil Oral, Product Type & Application
 Table 12. Global Key Manufacturers of Tadalafil Oral, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tadalafil Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tadalafil Oral as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tadalafil Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tadalafil Oral Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tadalafil Oral Sales Market Share by Region (2020-2025)
 Table 19. Global Tadalafil Oral Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tadalafil Oral Sales Market Share by Region (2026-2031)
 Table 21. Global Tadalafil Oral Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tadalafil Oral Revenue Market Share by Region (2020-2025)
 Table 23. Global Tadalafil Oral Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tadalafil Oral Revenue Market Share by Region (2026-2031)
 Table 25. North America Tadalafil Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tadalafil Oral Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tadalafil Oral Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tadalafil Oral Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tadalafil Oral Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tadalafil Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tadalafil Oral Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tadalafil Oral Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tadalafil Oral Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tadalafil Oral Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tadalafil Oral Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tadalafil Oral Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tadalafil Oral Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tadalafil Oral Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tadalafil Oral Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tadalafil Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tadalafil Oral Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tadalafil Oral Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tadalafil Oral Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tadalafil Oral Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tadalafil Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tadalafil Oral Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tadalafil Oral Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tadalafil Oral Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tadalafil Oral Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tadalafil Oral Sales (K Units) by Type (2020-2025)
 Table 51. Global Tadalafil Oral Sales (K Units) by Type (2026-2031)
 Table 52. Global Tadalafil Oral Sales Market Share by Type (2020-2025)
 Table 53. Global Tadalafil Oral Sales Market Share by Type (2026-2031)
 Table 54. Global Tadalafil Oral Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tadalafil Oral Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tadalafil Oral Revenue Market Share by Type (2020-2025)
 Table 57. Global Tadalafil Oral Revenue Market Share by Type (2026-2031)
 Table 58. Global Tadalafil Oral Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Tadalafil Oral Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Tadalafil Oral Sales (K Units) by Application (2020-2025)
 Table 61. Global Tadalafil Oral Sales (K Units) by Application (2026-2031)
 Table 62. Global Tadalafil Oral Sales Market Share by Application (2020-2025)
 Table 63. Global Tadalafil Oral Sales Market Share by Application (2026-2031)
 Table 64. Global Tadalafil Oral Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tadalafil Oral Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tadalafil Oral Revenue Market Share by Application (2020-2025)
 Table 67. Global Tadalafil Oral Revenue Market Share by Application (2026-2031)
 Table 68. Global Tadalafil Oral Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Tadalafil Oral Price (USD/Unit) by Application (2026-2031)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Eli Lilly Tadalafil Oral Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Tadalafil Oral Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Aurobindo Company Information
 Table 81. Aurobindo Description and Business Overview
 Table 82. Aurobindo Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Aurobindo Tadalafil Oral Product
 Table 84. Aurobindo Recent Developments/Updates
 Table 85. Sun Pharma Company Information
 Table 86. Sun Pharma Description and Business Overview
 Table 87. Sun Pharma Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Sun Pharma Tadalafil Oral Product
 Table 89. Sun Pharma Recent Developments/Updates
 Table 90. Alembic Pharmaceuticals Company Information
 Table 91. Alembic Pharmaceuticals Description and Business Overview
 Table 92. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Alembic Pharmaceuticals Tadalafil Oral Product
 Table 94. Alembic Pharmaceuticals Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Mylan Tadalafil Oral Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Tadalafil Oral Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Ajanta Pharma Ltd. Company Information
 Table 106. Ajanta Pharma Ltd. Description and Business Overview
 Table 107. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Ajanta Pharma Ltd. Tadalafil Oral Product
 Table 109. Ajanta Pharma Ltd. Recent Developments/Updates
 Table 110. Dr. Reddys Laboratories Company Information
 Table 111. Dr. Reddys Laboratories Description and Business Overview
 Table 112. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Dr. Reddys Laboratories Tadalafil Oral Product
 Table 114. Dr. Reddys Laboratories Recent Developments/Updates
 Table 115. Qilu Pharmaceutical Company Information
 Table 116. Qilu Pharmaceutical Description and Business Overview
 Table 117. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Qilu Pharmaceutical Tadalafil Oral Product
 Table 119. Qilu Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Tadalafil Oral Distributors List
 Table 123. Tadalafil Oral Customers List
 Table 124. Tadalafil Oral Market Trends
 Table 125. Tadalafil Oral Market Drivers
 Table 126. Tadalafil Oral Market Challenges
 Table 127. Tadalafil Oral Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tadalafil Oral
 Figure 2. Global Tadalafil Oral Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tadalafil Oral Market Share by Type: 2024 & 2031
 Figure 4. 2.5 mg tablets Product Picture
 Figure 5. 5 mg tablets Product Picture
 Figure 6. 10mg tablets Product Picture
 Figure 7. 20 mg tablets Product Picture
 Figure 8. Global Tadalafil Oral Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Tadalafil Oral Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Drug store
 Figure 12. Global Tadalafil Oral Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Tadalafil Oral Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Tadalafil Oral Sales (2020-2031) & (K Units)
 Figure 15. Global Tadalafil Oral Average Price (USD/Unit) & (2020-2031)
 Figure 16. Tadalafil Oral Report Years Considered
 Figure 17. Tadalafil Oral Sales Share by Manufacturers in 2024
 Figure 18. Global Tadalafil Oral Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Tadalafil Oral Players: Market Share by Revenue in Tadalafil Oral in 2024
 Figure 20. Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Tadalafil Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Tadalafil Oral Sales Market Share by Country (2020-2031)
 Figure 23. North America Tadalafil Oral Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Tadalafil Oral Sales Market Share by Country (2020-2031)
 Figure 27. Europe Tadalafil Oral Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Tadalafil Oral Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Tadalafil Oral Revenue Market Share by Region (2020-2031)
 Figure 35. China Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Tadalafil Oral Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Tadalafil Oral Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Tadalafil Oral Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Tadalafil Oral Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Tadalafil Oral Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Tadalafil Oral by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Tadalafil Oral by Type (2020-2031)
 Figure 57. Global Tadalafil Oral Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Tadalafil Oral by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Tadalafil Oral by Application (2020-2031)
 Figure 60. Global Tadalafil Oral Price (USD/Unit) by Application (2020-2031)
 Figure 61. Tadalafil Oral Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Tadalafil API Market Research Report 2025
Global Vardenafil Market Insights Forecast to 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Global Oral Medications for Erectile Dysfunction Market Research Report 2024
Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030
Oral Erectile Dysfunction Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Phosphodiesterase PDE inhibitors Market Insights Forecast to 2030
Global Phosphodiesterase Type 5 PDE5 Inhibitor Market Research Report 2025
Global Avanafil API Market Research Report 2025
Global Apremilast Reagent Market Research Report 2024
Global Erectile Dysfunction Oral Medications Market Research Report 2025
Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Erectile Dysfunction Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Tadalafil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti erectile Dysfunction ED Drugs Market Insights Forecast to 2030
Global PDE Inhibitors Market Research Report 2024
Erectile Dysfunction ED Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Udenafil Market Research Report 2025
Global Erectile Dysfunction Medicine Market Research Report 2024
Global Phosphodiesterase Inhibitor Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions